Introduction {#s1}
============

Plants exhibit remarkable developmental plasticity and their cells are typically considered totipotent, in that a complete plant can be regenerated from nearly any isolated individual cell. In intact plants, however, distinct cell lineages emerge and terminal fates are stable. A prime example of a specialized lineage is in the *Arabidopsis* leaf epidermis ([Figure 1A](#fig1){ref-type="fig"}) where asymmetric divisions of protodermal cells generate meristemoid mother cells (MMC) and meristemoids (M), self-renewing cells akin to transit amplifying cells in mammalian stem cell lineages ([@bib23]; [@bib36]). At the end of their renewing stages, these meristemoids differentiate into guard mother cells (GMCs), which undergo a single symmetric division to generate the paired guard cells (GCs) of the mature stomata. GCs and each of the intermediate stages leading to their formation are characterized by distinct morphologies and unique gene expression profiles, allowing experimental dissection of lineage progression in intact, developing organs ([@bib23]; [@bib36]).10.7554/eLife.03271.003Figure 1.FAMA and RBR physically interact and regulate guard cell division and differentiation.(**A**) Schematic of key stages in stomatal development mediated by bHLHs SPCH, MUTE and FAMA. Cell types are labeled as: meristemoid mother cell (MMC), meristemoid (M), stomatal lineage ground cell (SLGC), guard mother cell (GMC), guard cell (GC), pavement cell (PC). (**B** and **C**) Expression of FAMA and RBR in GMCs and GCs. Confocal images of 5-days post germination (dpg) cotyledon of FAMAp:GFP-FAMA (**B**, in green) and RBRp:RBR-CFP (**C**, in green). Inset in (**B**) is a *fama* mutant GMC at 10-dpg. Cell outlines (purple) were visualized with propidium iodide. (**D** and **E**) Reduction in RBR level leads to extra divisions in GCs. Confocal images of a co-suppressed RBRp:RBR-CFP line (**D**) and *FAMAp:amiRBR* expressing a CDKA1;1 reporter (green) (**E**). Yellow arrowheads in (**D**) indicate ectopic cell divisions. Cell outlines (white) were visualized with propidium iodide. (**F**) ClustalW2-based protein alignment of the LxCxE motif among FAMA relatives. (**G** and **H**) FAMA interacts with RBR in vivo and in vitro through its LxCxE motif. Representative images (**G**, left) and quantified data (**G**, right; rep: replicate) of Bimolecular Fluorescence Complementation (BIFC) analysis between FAMA and RBR. Pairs of CYCD/CYCD^LGK^-RBR and FAMA-bHLH93 ([@bib34]) were used as controls. (**H**) Yeast two-hybrid interaction assays between FAMA and RBR. (**I**) Complementation of seedling lethality in *fama* mutants by FAMA^LGK^ (*FAMAp:FAMA*^*LGK*^*; fama*). (**J**--**L**) Diversity of GC defects in adaxial cotyledon epidermis of 12-dpg FAMA^LGK^. DIC images of a mature GC showing strong phenotype (**J**, false red colors indicate different GC units within another) and a broader view of GCs with different defects (**K**). Key: ectopic asymmetric divisions (arrowheads), new GC units (asterisks), properly spaced divisions and GC units (brackets). Inset shows a lobed GC. (**L**) Quantitation of different classes of GC defects (cartoons on Y-axis) in FAMA^LGK^ at 6, 9 and 12-dpg. Bars represent the percentages of each class over all GCs on adaxial cotyledons. All images are at the same magnification (including insets in **B** and **K**). Scale bar, 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.03271.003](10.7554/eLife.03271.003)10.7554/eLife.03271.004Figure 1---figure supplement 1.Additional images of FAMA promoter-driven expression of amiRBR and of FAMA^LGK^-YFP.(**A**) Reduction of RBR levels under the FAMA promoter (*FAMAp:amiRBR*) drives ectopic cells divisions exclusively in guard cells (black arrowheads). (**B**--**C**) Expression pattern of YFP-tagged FAMA^LGK^ (*FAMAp:FAMA*^*LGK*^*-YFP,* green*)* rescuing the *fama* mutant is indistinguishable from the wild type in guard cells (GCs) of 6-dpg cotyledons; it first appears in GMCs (single green nuclei), persists into young GCs (pairs of green nuclei), but disappears before GCs mature and make full pores. (**D**) When ectopic GCs divisions appear, FAMA^LGK^-YFP is absent from most divisions but only appears in cells (top left) that are likely new GMCs based on morphology. Cell outlines (purple) were visualized with propidium iodide. Scale bar in **A**, 50 μm, scale bars in **B**--**D**, 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.03271.004](10.7554/eLife.03271.004)10.7554/eLife.03271.005Figure 1---figure supplement 2.Categorization of guard cell (GC) defects and increase in severity over time in FAMA^LGK^.(**A**) DIC images of distinguishable phenotypic defects in GCs in FAMA^LGK^ plants (*FAMAp:FAMA*^*LGK*^*; fama*). For quantification analysis, 13 distinct phenotypes (1--13) were identified at appreciable frequencies and grouped into 5 phenotypic classes (box). (**B**) GC defects of a second, independent FAMA^LGK^ line from the one characterized in [Figure 1L](#fig1){ref-type="fig"} at 6, 9 and 12-dpg; note similar results between the two lines. Cartoons of GCs on the Y-axis indicate the 5 phenotypic classes scored. Bars represent the average percentages of each phenotypic class over total number of GCs (± SEM) in 0.320 mm^−2^ DIC images of adaxial cotyledons at the indicated age.**DOI:** [http://dx.doi.org/10.7554/eLife.03271.005](10.7554/eLife.03271.005)

The basic helix-loop-helix (bHLH) transcription factor FAMA is a master regulator of guard cell identity; it is necessary and sufficient for GC fate acquisition and its epidermal expression is limited to GMCs and young GCs ([@bib34]) and ([Figure 1B](#fig1){ref-type="fig"}). GMCs are made in *fama* mutants, but they fail to progress into GCs and instead continue dividing while maintaining expression of earlier fate markers ([@bib34]) and ([Figure 1B](#fig1){ref-type="fig"}, inset); this failure to make GCs results in seedling lethality ([@bib34]) and ([Figure 1I](#fig1){ref-type="fig"}). Overexpression of FAMA reprograms other cells into GC identity, while simultaneously repressing cell division to yield single-celled stomata ([@bib34]). The mechanisms by which FAMA regulates cell division and terminal differentiation are not known, but FAMA\'s direct targets include cell cycle regulators and genes associated with mature guard cell function ([@bib15]). FAMA has been shown to act as a transcriptional activator ([@bib34]) but can also participate in repression of certain cell cycle targets ([@bib15]). Here we show that FAMA is required for the irreversible differentiation of GCs and that it fulfills this role through recruitment of the *Arabidopsis* Retinoblastoma homologue, RETINOBLASTOMA-RELATED (RBR). Point mutations that disrupt FAMA-RBR interactions render FAMA capable of promoting initial GC identity, but unable to maintain commitment. By demonstrating FAMA-promoted binding of RBR to the regulatory regions of stomatal regulators whose genomic regions contain repressive chromatin marks, we define a molecular mechanism by which the ubiquitously expressed RBR is recruited to specific genomic contexts at specific times to regulate key developmental events.

Results {#s2}
=======

RBR is broadly expressed in *Arabidopsis* development and reduction of RBR activity has been correlated with excess division and loss of cell identity in many different contexts, including the early stomatal lineage ([@bib1]). In the epidermis of actively dividing young leaves, RBRp:RBR-CFP ([@bib8]) is expressed in all cell nuclei; as the leaf matures, expression becomes restricted to stomatal lineage cells ([Figure 1C](#fig1){ref-type="fig"}). Mosaic co-suppression of the *RBRp:RBR-CFP* transgene leads to loss of fluorescence and concomitant excessive divisions in the CFP-minus sectors, suggesting that RBR represses cell divisions in both the early lineage and the terminally differentiated GCs ([Figure 1D](#fig1){ref-type="fig"}). To examine RBR\'s role specifically in the GCs, we drove expression of artificial microRNAs (amiRNAs) against RBR by the FAMA promoter. *FAMAp:amiRNA-RBR* GCs underwent inappropriate extra divisions oriented transverse to the long axis of the cells, while other epidermal cells were not affected, confirming a direct requirement for RBR in GCs ([Figure 1E](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}) and confirming phenotypes reported using different amiRNAs directed against RBR ([@bib25]).

FAMA encodes a canonical RBR binding motif (LxCxE) ([@bib4]) that is conserved among dicot FAMA orthologs, but not in FAMA\'s closest paralogs SPEECHLESS (SPCH) and MUTE ([Figure 1F](#fig1){ref-type="fig"}). LxCxE-dependent physical interaction between FAMA and RBR was tested by *in planta* Bimolecular Fluorescence Complementation (BiFC) ([Figure 1G](#fig1){ref-type="fig"}) and yeast two-hybrid ([Figure 1H](#fig1){ref-type="fig"}) assays. In both assays, WT FAMA, but not a version bearing point mutations changing the Cysteine (C) and Glutamate (E) in the LxCxE motif to Glycine (G) and Lysine (K) (FAMA^LGK^) could interact with RBR. Importantly, FAMA^LGK^ could still interact with its dimerization partner bHLH93 ([@bib34]) ([Figure 1G](#fig1){ref-type="fig"}), indicating that the FAMA^LGK^ variant maintains its overall structural integrity.

We then asked whether physical interaction with RBR was required for FAMA function in the context of normal leaf development. *FAMAp:FAMA*^*LGK*^ was tested for its ability to complement *fama* lethality and defects in GC differentiation, and *FAMAp:FAMA*^*LGK*^*-YFP* was monitored to determine whether the LCE→LGK modification altered FAMA\'s expression, stability or subcellular localization. In young cotyledons and leaves, *FAMAp:FAMA*^*LGK*^*-YFP* was exclusively nuclear. Like G/YFP-tagged versions of FAMA published previously ([@bib34]; [@bib37]; [@bib25]), *FAMAp:FAMA*^*LGK*^*-YFP* is first apparent in GMCs, remains highly expressed as the GMCs undergo cell division, and is downregulated as GCs mature such that stomata with clearly defined pores express the protein at low levels or not at all ([Figure 1B](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1B--C](#fig1s1){ref-type="fig"}). Plants of genotype *fama;FAMApro:FAMA*^*LGK*^ (hereafter referred to as FAMA^LGK^ plants) were recovered and were moderately healthy and fertile, though smaller than wild type, indicating that FAMA^LGK^ was sufficient to rescue *fama* lethality ([Figure 1I](#fig1){ref-type="fig"}). In the GCs of rescued FAMA^LGK^ plants, however, we observed excessive cell divisions, changes in cell morphology, and, most strikingly, production of paired GCs inside of existing GCs ([Figure 1J--L](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}, phenotypic classes 6--11).

Phenotypes conferred by FAMA^LGK^ and by manipulating RBR in the late stomatal lineage both involved increased cell division, but were not identical. To improve phenotypic resolution, we characterized the expression patterns of cell fate and cell cycle markers in FAMA^LGK^ and *FAMAp:amiRBR* plants ([Figure 2](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). This detailed analysis revealed clear phenotypic differences between reducing RBR levels in GMCs and reducing RBR\'s interaction with FAMA ([Figure 2---figure supplement 1A--B](#fig2s1){ref-type="fig"}). Notably, the FAMA^LGK^ phenotype results, not from chaotic or uncontrolled divisions and fate changes, but rather an orderly reiteration of stomatal lineage progression. This manifested itself as a progressive increase in phenotypic severity with age ([Figure 1L](#fig1){ref-type="fig"}) and by the appearance of stomatal lineage markers in patterns suggesting that the GCs reverted to MMC identity and proceeded through the intermediate stages of the pathway normally ([Figure 2](#fig2){ref-type="fig"}). Expression of stomatal-promoting transcription factors (SPCH, MUTE, FAMA, [Figure 2A--C](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), stomatal-restricting signaling elements (TMM, EPF1, EPF2, [Figure 3A--D](#fig3){ref-type="fig"}), and general division reporters (*CDKA1;1*, [Figure 2B--C](#fig2){ref-type="fig"}) followed the normal temporal patterns, and ectopic GC divisions appeared to follow early lineage division rules. For example, when a 'reprogrammed' GC produced two stomata, they were separated by a non-stomatal cell, indicating that spacing divisions occurred. Distinct cell orientations characteristic of amplifying divisions were also visible ([Figure 2B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Further evidence for normal asymmetric divisions is polarized localization of BASL ([@bib12]) in the larger daughter of a GC division ([Figure 3E](#fig3){ref-type="fig"}). Based on the lack of expression of stomatal lineage markers ([Figure 2D](#fig2){ref-type="fig"}), we interpret the lobed GCs we observe at low, but significant, frequencies in FAMA^LGK^ plants ([Figure 1K](#fig1){ref-type="fig"}, inset, and [Figure 1L](#fig1){ref-type="fig"}) as cells that are transdifferentiating into an epidermal pavement cell identity.10.7554/eLife.03271.006Figure 2.Disruption of FAMA-RBR interaction leads to failure of terminal differentiation and reiteration of stomatal lineage divisions and gene expression programs.(**A**) Diagram of stages of stomatal development (abbreviated and color-coded as in [Figure 1A](#fig1){ref-type="fig"}) and expression window of bHLH transcription factors SPCH, MUTE and FAMA. (**B**) Characterization of GC defects in FAMA^LGK^ plants accompanied by key stomatal reporters. Wild type-looking GCs of FAMA^LGK^ plants re-iterate the stomatal developmental pathway, undergo further divisions and exhibit correct orderly expression of stage-specific stomatal regulators and cell cycle genes. Each column from left to right represents a stage in the progression of the stomatal lineage (abbreviated as in [Figure 1A](#fig1){ref-type="fig"}). Rows from top to bottom show expression patterns of plasma membrane (PM) marker (row 1), and reporters of SPCH (row 2, beige), MUTE (row 3, orange), FAMA^LGK^ (row 4, red) and CDKA1;1 (row 5). Images are of independent GCs of adaxial cotyledons at 6, 9 or 12-dpg. (**C**) Expression of each marker (rows 1 to 5) in GCs that underwent amplifying or spacing divisions. (**D**) Guard cells exhibiting pavement cell-like lobed growth with no divisions or expression of stomatal and cell cycle reporters. Cell outlines (purple) were visualized with propidium iodide or ML1p:mCherry-RCI2A. Autofluorescence of chloroplasts (blue spheres) may be visible in some images. All images are at the same magnification. Scale bar, 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.03271.006](10.7554/eLife.03271.006)10.7554/eLife.03271.007Figure 2---figure supplement 1.Expression of cell cycle and stomatal reporters in FAMA^LGK^ plants (*FAMAp:FAMA*^*LGK*^*;fama*) and amiRBR (*FAMAp:amiRBR*) mutants and examples of timelapse images for SPCH and MUTE markers.(**A**) GUS staining of transcriptional reporters for cell cycle genes *CDKB1;1* and *CDC6* (rows) in WT Col (left column), amiRBR (middle), and FAMA^LGK^ plants (right column). Note that the pattern and levels of expression differ between the RBR knockdown line (amiRBR) and when the interaction between FAMA and RBR is disrupted (FAMA^LGK^). In the amiRBR line, *CDKB1;1* and *CDC6* are strongly expressed in both GCs, each of which displays ectopic cell divisions (outline in left guard cell and arrowheads in the right guard cell). Broad expression of *CDKB1;1* and *CDC6* is consistent with RBR\'s function as a direct repressor of the transcription factor E2F and its cell cycle target genes required for the G1 to S-phase transition ([@bib14]). In FAMA^LGK^ plants, however, *CDKB1;1* and *CDC6* are restricted to only some stomatal cell divisions (stars mark new GCs and arrows mark amplifying ACDs). Expression of *CDKB1;1* and *CDC6* are likely consequences of regulated cell divisions as the mutant GCs progress through the stomatal lineage. (**B**) Confocal images of stomatal lineage reporters in GCs of amiRBR. Cell outlines are visualized with propidium iodide (purple). Arrowheads correspond to ectopic cell divisions. Of the reporters tested, SPCH and MUTE are weakly and infrequently seen (\<20% of GCs) and only in GCs with many ectopic divisions (green asterisks). TMM and EPF2, however, were not detectable. Small blue disks visible in these cells are chloroplasts. Scale bar, 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.03271.007](10.7554/eLife.03271.007)10.7554/eLife.03271.008Figure 2---figure supplement 2.Timelapse imaging of cell fate reporters in FAMA^LGK^ lines.(**A**--**B**) Examples of MUTE expression in reprogrammed guard cells. MUTE expression always appears after an asymmetric division and before a symmetric division to create a new guard cell pair. (**C**--**D**) Examples of SPCH expression. SPCH appears before divisions, persists after division in both daughters, but then becomes undetectable in one daughter (white arrowheads track expressing cells in **C**). SPCH expression has disappeared before cells undergo symmetric divisions to create the new guard cell pair. All images are from abaxial cotyledons placed in the timelapse imaging chamber at 6 days post germination. Time relative to first panel image in hours:minutes is indicated in the bottom right corner of each image. Because development is asynchronous, T0 is a different absolute time for each montage.**DOI:** [http://dx.doi.org/10.7554/eLife.03271.008](10.7554/eLife.03271.008)10.7554/eLife.03271.009Figure 2---figure supplement 3.Guard cells in FAMA^LGK^ plants reiterate the stomatal developmental pathway and undergo stereotypic stomatal asymmetric cell divisions that generate the diversity in phenotype.(**A**) Diagram of three types of asymmetric cell division (ACD) in the stomata lineage. Entry division (black) of a meristemoid mother cell (MMC) initiates the lineage and results in the formation of a meristemoid (M) and a stomatal lineage ground cell (SLGC). Amplifying division (green) denotes a subsequent ACD of a meristemoid. Spacing division (blue) is the ACD of a SLGC, where the newly formed M is spaced away from existing M, guard mother cell (GMC) or guard cells (GCs). (**B**) GCs of FAMA^LGK^ plants re-enter the stomatal lineage and can undergo the three types of stomatal ACD. DIC images of GCs from FAMA^LGK^ plants illustrating the entry (black), amplifying (green) and spacing (blue) divisions and their subsequent progression in the lineage (left to right). Images were false colored to indicate MMC (light blue), M (beige), GMC (orange), GC (red).**DOI:** [http://dx.doi.org/10.7554/eLife.03271.009](10.7554/eLife.03271.009)10.7554/eLife.03271.010Figure 3.Reprogrammed FAMA^LGK^ guard cells re-express early stomatal signaling components and polarity regulators.(**A**) Diagram of stages of stomatal development (abbreviated as in [Figure 1A](#fig1){ref-type="fig"}) and expression window of signaling and polarity regulators indicated as bars spanning lineage stages. Re-expression of TMMp:TMM-YFP (**B**), EPF1p:YFP~nuc~ (**C**), EPF2p:YFP~nuc~ (**D**), and BASLp:YFP-BASL (**E**) in GCs from adaxial cotyledons of 6-dpg FAMA^LGK^ seedlings. Arrowhead in (**E**) indicates the polarized crescent characteristic of BASL in asymmetrically dividing cells. Cell outlines (purple) were visualized with propidium iodide. Scale bar, 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.03271.010](10.7554/eLife.03271.010)

In *FAMAp:amiRBR* lines, by contrast, excessive GC division was accompanied by elevation of cell cycle gene expression throughout the GCs (CDKA1;1, [Figure 1E](#fig1){ref-type="fig"} , CDKB1;1 and CDC6, [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), but only rarely by misexpression of early stomatal lineage markers ([Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}). Consistent with gene expression behaviors, spacing and amplifying divisions were not seen in *FAMAp:amiRBR* cotyledon GCs at any appreciable frequency (\<1/1000 GCs) in 6--12 day old plants. Expression of an additional copy of tagged RBR (RBR-CFP), however, does not alter divisions in the stomatal lineage; we observed neither arrested cells nor hyperproliferating cells ([Figure 4A--B](#fig4){ref-type="fig"}). In FAMA^LGK^ plants, GCs that undergo extra divisions re-express RBR as would be expected from RBR\'s normal expression pattern in the early stomatal lineage ([Figure 4C--G](#fig4){ref-type="fig"}).10.7554/eLife.03271.011Figure 4.Expression of RBRp:RBR-CFP reappears in reprogramed FAMA^LGK^ guard cells.RBRp:RBR-CFP (green) is expressed in GMCs and young GCs, but expression in WT does not confer any guard cell phenotype at 6-dpg (**A**) or 12-dpg (**B**). Reprogrammed guard cells in FAMA^LGK^ plants re-express RBR in specific cells (green) as they recapitulate the stomatal development pathway and undergo precursor divisions. Meristemoid mother cell (MMC) and meristemoid (M) divisions (asterisks) captured at 6-dpg (**C**) and GMC and spacing asymmetric cell division (ACD) captured at 12-dpg (**D**--**G**). Cell outlines in confocal images are visualized with propidium iodide (purple). Small disks visible in color in these cells are chloroplasts. Scale bar, 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.03271.011](10.7554/eLife.03271.011)

Expression of early stomatal markers indicated that FAMA^LGK^ GCs re-acquired stomatal precursor identities, but did these cells return to an even earlier stem-cell or embryonic identity? Moreover, was a change in identity tied to failure of FAMA^LGK^ to activate its normal downstream targets? We addressed these questions by monitoring gene expression in isolated 12-dpg cotyledons of WT (Col) and FAMA^LGK^ plants ([Figure 5A](#fig5){ref-type="fig"}). Analysis of genes shown in [Figures 2 and 3](#fig2 fig3){ref-type="fig"} to be inappropriately up-regulated in FAMA^LGK^ verified that a qRT-PCR-based approach could accurately assess gene expression changes ([Figure 5A](#fig5){ref-type="fig"}, bracket indicating stomatal precursor genes). There was a dramatic increase in expression levels for the stomatal precursor genes, but variable change in expression of mature GC genes, consistent with a situation in which the overproduction of GCs through repeated re-entry is balanced by the loss of identity of older GCs ([Figure 5A](#fig5){ref-type="fig"}, mature GC genes). FAMA^LGK^ was also still capable of up-regulating several, but not all, of the direct targets reported in ([@bib15]) ([Figure 5A](#fig5){ref-type="fig"}, FAMA direct targets). When expression of shoot meristem (*SHOOT MERISTEMLESS, STM*), root meristem (*WUS HOMEOBOX, WOX5*) or embryo genes (*WOX9, WOX2, FUSCA3 (FUS3), LEC1*) ([@bib3]; [@bib10]) was monitored in FAMA^LGK^ plants, however, we found no evidence that cells were being reprogrammed into embryonic or other stem-cell-like fates ([Figure 5A](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Taken together, the gene expression data indicate that disruption of FAMA-RBR interaction via the FAMA^LGK^ modification leads to a stomatal lineage-specific loss of terminal commitment.10.7554/eLife.03271.012Figure 5.Terminal differentiation of guard cells may be mediated by FAMA-guided recruitment of RBR to suppress stomatal regulatory genes.(**A**) Expression analysis in mature cotyledons (12-dpg) of FAMA^LGK^ and wild type (Col) by quantitative RT-PCR. Signals were normalized to ACTIN2 and then to Col. Values shown are means ± SEM. UD, undetected. Asterisks indicate significant difference (Student\'s *[t]{.ul}* test, \* p \< 0.05). (**B**--**D**) Binding of FAMA and RBR to regulatory regions of stomatal genes. ChIP assays were performed with FAMAp:FAMA-MYC in *fama* (**B**), FAMAp:RBR-MYC in Col (**C**), and FAMAp:RBR-MYC in FAMA^LGK^ (*FAMAp:FAMA*^*LGK*^*;fama*) (**D**) using an anti-Myc antibody as in ([@bib24]). ChIPed DNA was quantified by qPCR with primers specific to the indicated gene promoters or the negative control region, IR1 ([@bib8]). Input-adjusted signals were normalized to Col. Values are means ± SEM. (**E**) FAMA promoter-driven expression of SPCH in wild type is not sufficient to reprogram guard cells to FAMA^LGK^ phenotype. Confocal image of FAMAp:SPCH-YFP (green) in 12-dpg cotyledon visualized with propidium iodide (purple). Scale bar, 10 μm. (**F**) The stomatal lineage represents a stem-cell like lineage that is distinct from other stem-cell like compartments in the shoot, root or embryo. The FAMA-RBR module maintains terminal differentiation of guard cells (GCs) through repression of the early stomatal lineage genes, likely made permanent by chromatin modification. In FAMA^LGK^ plants, RBR is no longer recruited to *SPCH* and other stomatal lineage gene promoters allowing inappropriate re-expression of these genes and subsequent reiteration of the stomatal development pathway.**DOI:** [http://dx.doi.org/10.7554/eLife.03271.012](10.7554/eLife.03271.012)10.7554/eLife.03271.013Figure 5---figure supplement 1.Validation of primers for the stem cell markers FUS3, LEC1, STM and WOX9.RT-PCR reactions for RNA extracted from immature siliques of Arabidopsis. Target size of the amplified products is indicated in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. Lanes: molecular weight DNA ladder (MW), independent RNA samples (1, 2, 3), negative controls (−). Gel was stained with ethidium bromide.**DOI:** [http://dx.doi.org/10.7554/eLife.03271.013](10.7554/eLife.03271.013)10.7554/eLife.03271.014Figure 5---figure supplement 2.Generation of transgenic lines expressing Myc-tagged RBR driven by FAMA promoter, in vivo immunoprecipitation of the RBR-Myc protein and phenotypic analysis of the transgenic lines.(**A**) Western detection of RBR-Myc in transgenic plants harboring the *FAMAp:RBR-MYC* construct in either Col (lines 1--4) or FAMA^LGK^ (lines 1--3) backgrounds. Total protein was extracted from 5-dpg seedlings of the indicated genotypes and probed with α-Myc antibody. Recombinant RBR-Myc has a calculated M.W. of 128.5 kDa. (**B**) *In vivo* pull-down assay of stomatal lineage expressed RBR-MYC from transgenic plants. Total soluble protein from Col and *FAMAp:RBR-MYC* (in Col) was incubated with an anti-Myc antibody. Precipitated samples were probed with the same antibody in Western analysis. IB: Immunoblot, IP: Immunoprecipitation. (**C**--**F**) Confirmation that expression of FAMAp:RBR-MYC does not alter guard cell development. (**C**--**F**) Confocal images of 6-dpg cotyledons and DIC images of 12-dpg cotyledons of wild type and *FAMAp:RBR-MYC* plants. Transgenic plants harboring the *FAMAp:RBR-MYC* construct (**E**--**F**) do not exhibit changes in GC divisions (neither fewer, nor more divisions are found) and are indistinguishable from wild type (**C**--**D**) at 6 and 12-dpg. Cell outlines (purple) in confocal images were visualized with propidium iodide. All images are at the same magnification. Scale bar, 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.03271.014](10.7554/eLife.03271.014)10.7554/eLife.03271.015Figure 5---figure supplement 3.Biological replicates for ChIP experiments in [Figure 5](#fig5){ref-type="fig"}.ChIP assays were performed with FAMAp:FAMA-MYC in Col (**A**), FAMAp:RBR-MYC in Col (**B**), and FAMAp:RBR-MYC in FAMA^LGK^ plants (**C**) using an anti-Myc antibody as in ([@bib24]). ChIPed DNA was quantified by qPCR with primers specific to the indicated gene promoters or the negative control region, IR1 or RB45 ([@bib8]) and ([@bib45]). Input-adjusted signals were normalized to Col. Values are means ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.03271.015](10.7554/eLife.03271.015)10.7554/eLife.03271.016Figure 5---figure supplement 4.Dissection of FAMA and RBR binding on stomatal target genes.(**A** and **D**) Map of the *SPCH* (**A**) and *EPF1* (**D**) loci. Arrow indicates orientation of the gene and the transcription start site. Genome coordinate is indicated above the gene structure. Black bars indicate genomic region probed by ChIP-qPCR assays. Key: U, upstream; P, promoter; D, downstream. (**B**, **C**, **E** and **F**) ChIP assays were performed with FAMAp:FAMA-MYC in *fama* (**B** and **E**) and FAMAp:RBR-MYC in Col (**C** and **F**), using an anti-Myc antibody as in ([@bib24]). ChIPed DNA was quantified by qPCR with primers specific to the indicated genomic regions relative to *SPCH* (**B** and **C**) and *EPF1* (**E** and **F**) or the negative control region, RB45 ([@bib45]). Input-adjusted signals were normalized to Col. Values are means ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.03271.016](10.7554/eLife.03271.016)

By what molecular mechanism might this specific loss of commitment take place? Analysis of chromatin states in maturing leaves revealed H3K27me3 (a chromatin mark associated with transcriptional repression) in the genomic regions of *SPCH, MUTE, FAMA, EPF1* and other stomatal genes ([@bib21]), and a recent report showed that manipulation of a member of the POLYCOMB REPRESSIVE COMPLEX 2 (PRC2) can alter developmental regulation of H3K27me3 deposition at *SPCH* and *MUTE* loci ([@bib26]). Animal and plant Rb/RBR proteins can serve as interaction bridges between chromatin modifying enzymes and specific genomic contexts ([@bib4]; [@bib14]) and RBR was previously found to be associated with SPCH regulatory regions via ChIP in whole seedlings ([@bib45]). Therefore it is plausible that, as the final master regulator bHLH in the stomatal pathway, FAMA (with RBR) ensures terminal differentiation of GCs by facilitating stable repression of early stomatal lineage genes. To test this model, we assayed the co-association of FAMA and RBR with regulatory regions of three key stomatal lineage genes that have significant H3K27me3 coverage (*SPCH, FAMA and EPF1*) and, as specificity controls, two cell cycle genes known to be RBR targets ([@bib33]). Because RBR is essential and expressed in nearly all cells, to accurately assay its role as a potential partner of FAMA in the stomatal lineage, we generated a Myc-tagged version of RBR expressed under the FAMA promoter (*FAMAp:RBR-MYC*). We confirmed that expression of this transgene did not alter stomatal development and that we could effectively immunoprecipitate it from plants ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). In ChIP assays, *SPCH*, *FAMA* and *EPF1* were all targets of FAMA and of stomatal lineage-expressed RBR ([Figure 5B--C](#fig5){ref-type="fig"} and [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}). Further dissection of the binding regions at *SPCH* and *EPF1* indicates that FAMA and RBR are enriched in the same pattern, suggesting that they bind as part of the same complex ([Figure 5---figure supplement 4](#fig5s4){ref-type="fig"}). We then tested the key prediction of our model--that association of RBR with a stomatal target gene is dependent on its interaction with FAMA. ChIPs of FAMAp:RBR-MYC in a FAMA^LGK^ background showed that RBR enrichment at the promoters of *SPCH* and *FAMA*, but not of the general RBR target gene *PCNA*, was significantly reduced ([Figure 5D](#fig5){ref-type="fig"} and [Figure 5---figure supplement 4](#fig5s4){ref-type="fig"}), consistent with our recruitment model. RBR enrichment at the promoter of a negative regulator of stomatal development, *EPF1*, was more variable in our assays, sometimes showing little change ([Figure 5D](#fig5){ref-type="fig"}), but failing to associate with RBR in other replicates ([Figure 5---figure supplement 3C](#fig5s3){ref-type="fig"}).

The association of FAMA and RBR with the *SPCH* locus is intriguing, as in normal development SPCH is required for initiation of the stomatal lineage and is essential for robust expression of all stomatal genes so far reported ([@bib27]; [@bib37]; [@bib19]). In theory, failure of FAMA^LGK^ to stably repress *SPCH* expression could, by itself, be sufficient to reinitiate the stomatal lineage program. If this were true, ectopic expression of SPCH in GCs should recapitulate the FAMA^LGK^ phenotype. Expression of FAMAp:SPCH-YFP (or its hyperactive variants FAMAp:SPCH1-4A or FAMAp:SPCH2-4A \[[@bib22]\]) in an otherwise WT background, however, did not mimic FAMA^LGK^ ([Figure 5E](#fig5){ref-type="fig"}). This suggests that competence to reinitiate the stomatal pathway requires more than expression of a single 'trigger' gene, but rather a more generally permissive expression state, a fact supporting a broader chromatin regulating role for the FAMA-RBR complex ([Figure 5F](#fig5){ref-type="fig"}).

Discussion {#s3}
==========

Recently, physical associations between RBR and the *Arabidopsis* transcription factor SCARECROW (SCR) were found to be essential for modulating stem-cell behavior in the root ([@bib8], [@bib9]). Both SCR and FAMA bind to RBR via an LxCxE motif, yet the consequences of these transcription factor/RBR interactions are different; RBR antagonizes SCR function in asymmetric division in the root stem cell compartment ([@bib8], [@bib9]), whereas RBR and FAMA have similar functions promoting differentiation at the terminal stage of stomatal development. Yet, while different RBR/transcription factor complexes may be customized for unique developmental contexts, the underlying molecular mechanisms of gene regulation might be similar. As with FAMA targets, RBR is required for repression of SCR target genes and can associate with their promoter regions, but there have been no experiments addressing whether disrupting association of SCR and RBR affects either proteins\' chromatin association. In this study, we provide key data in support of a specific molecular mechanism for transcriptional repression utilizing RBR in combination with cell-type specific transcription factors: first, we demonstrate, through cell-type specific ChIPs, that RBR is associated with the promoter of the stomatal lineage initiator *SPCH* in cells as they are committing to terminal fates and second, we show that this binding is reduced when RBR\'s interaction with FAMA is disrupted. Thus, our data provide strong support for RBR being recruited by cell-type specific transcription factors to lead to transcriptional repression of their targets ([Figure 5F](#fig5){ref-type="fig"}).

We observed significant changes in RBR association with *SPCH* and *FAMA* regulatory regions in FAMA^LGK^ lines; however, RBR was still associated with the *EPF1* locus in some experimental replicates. This could indicate that there are FAMA-independent ways to recruit RBR to this site, or that our FAMA^LGK^ manipulation does not eliminate all FAMA-RBR interactions in the endogenous complex. It is interesting, however, that EPF1 differs from SPCH and FAMA in being a repressor of stomatal development and thus alleviation of the repression of *EPF1* would be expected to antagonize reprogramming to a stomatal precursor identity.

The role of PRC2 complex protein CURLY LEAF (CLF) was recently investigated in connection to stomatal lineage termination and was found to promote the accumulation of H3K27me3 marks on early stomatal lineage genes ([@bib26]). These data complement ours in connecting chromatin modification to stable acquisition of terminal cell identities in the stomatal lineage. Additionally, ([@bib26]) report phenotypes, similar to, but milder than those seen in FAMA^LGK^, caused by prolonged expression of a C-terminal GFP-tagged version of FAMA (FAMA^trans^). In a timepoint and tissue common to their data and this study (12 day old cotyledons), FAMA^LGK^ plants display reprogramming of ∼80% guard cells ([Figure 1L](#fig1){ref-type="fig"}) compared with 10% of FAMA^trans^. Lee et al. interpret reinitiation of divisions in guard cells as resulting from a gain of FAMA function, however, this interpretation is at odds with previously published data that FAMA overexpression limits cell division ([@bib34]; [@bib15]) and is difficult to reconcile with most models of chromatin-mediated repression of transcription. In light of our data showing that a loss of a specific FAMA activity (RBR binding) produces strong lineage reprogramming, we think a more parsimonious explanation of the FAMA^trans^-induced phenotype is that blocking of the FAMA C-terminus by addition of GFP creates a protein that dominantly interferes with FAMA-RBR interactions.

By independently manipulating RBR levels and RBR-FAMA interactions in terminally differentiating GCs, we could uncouple division and fate modulating roles of RBR. Notably, depletion of RBR in many contexts leads to hyperproliferation and derepression of cell cycle promoting genes ([Figure 1E](#fig1){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} and [@bib1]; [@bib43]; [@bib45]). This is in contrast to phenotypes that dominate when its association with FAMA is disrupted; namely that specific cell fates and division behaviors and their accompanying gene expression patterns re-emerge in an orderly pattern. RBRp:RBR-CFP itself becomes ectopically expressed in re-dividing FAMA^LGK^ GCs. Were RBR to be playing its cell-cycle repressive role in this context, one would expect this ectopic expression might completely halt divisions. That the opposite occurs, however, suggests a qualitatively different role for RBR in combination with FAMA in these cells. Because *RBR* is expressed in all cells of the plant, it is difficult to measure whether our cell-type specific amiRNA completely eliminated *RBR* in guard cells, but our data suggest that RBR\'s cell-cycle repression activity is more sensitive to dosage than its activity modulating stomatal gene expression. Only by retaining RBR levels but disrupting the FAMA-dependent activity was a clear role for RBR in terminal differentiation unmasked.

In the balance between proliferation and differentiation, between developmental flexibility and robust fate commitment, several decades of cell culture and animal genetic knockout studies have placed Rb family proteins in key, if disputed, roles ([@bib6]; [@bib13]; [@bib40]). Regulation of the stomatal lineage can parallel that of stem cell populations in animals at cellular, developmental and molecular levels. Both plant stomatal and mammalian myogenic lineages, for example, employ series of paralogous bHLHs during fate specification and differentiation, and activities of these bHLHs are regulated through conserved upstream kinases and by association with Rb/RBR (reviewed in [@bib28]). Bound by immobile cell walls, stomatal lineage cells leave a record of their fate and division history in their marker expression and spatial arrangement on the leaf surface. This plant model, therefore, provides a unique opportunity to dissect cell division and cell fate activities of Rb and other conserved proteins during programming and reprogramming and is a powerful comparative system for future discoveries of fundamental regulatory mechanisms of stem cell initiation, maintenance and termination.

Materials and methods {#s4}
=====================

Plant material and growth conditions {#s4-1}
------------------------------------

*Arabidopsis thaliana* Columbia-0 (Col) was used as wild type in all experiments. All mutants and transgenic lines tested are in this ecotype. The following previously described mutants and reporter lines were used in this study: *fama-1* and *FAMAp:GFP-FAMA* ([@bib34]); *MUTEp:MUTE-GFP* ([@bib37]); *KAT1p:GUS* ([@bib32]); *CDKB1;1p:GUS* ([@bib2]); *CDC6p:GUS* ([@bib5]), *RBRp:RBR-CFP* ([@bib8]) and *CDKA;1p:YFP-DB* ([@bib18]). The CDKA;1 reporter contains a destruction box (DB) within the YFP fusion to ensure that reporter expression does not persist after a cell division. Versions of reporters previously published with different fluorescent proteins include: *SPCHp:SPCH-YFP* ([@bib27]), TMMp:TMM-YFP ([@bib29]), *EPF2p:YFP*~*nuc*~ ([@bib17]), *EPF1p:YFP*~*nuc*~ ([@bib16]), *ML1p:mCherry-RCI2A* ([@bib39]), and *BASLp:YFP-BASL* ([@bib12]). Seedlings were grown on 0.5 Murashige and Skoog (MS) medium at 22°C under 16 hr-light/8 hr-dark cycles and were examined at the indicated time.

Vector construction and plant transformation {#s4-2}
--------------------------------------------

The FAMA promoter (2.5 kb, \[[@bib34]\]) and full-length cDNAs of FAMA and RBR were cloned into Gateway compatible entry vectors, typically pENTR/D-TOPO (Life Technologies, Carlsbad, CA), to facilitate subsequent cloning into plant binary vectors. To mutate the LxCxE motif of FAMA to LxGxK, site directed mutagenesis was performed using the QuikChange II Kit (Agilent, Santa Clara, CA). Gateway entry vectors containing the FAMA promoter and FAMA^LGK^ cDNA were recombined into the plant binary destination vectors pHGY ([@bib20]) and pGWBI ([@bib30]) to generate YFP-tagged and untagged versions of *FAMAp:FAMA*^*LGK*^, respectively. For the *FAMAp:amiRBR* construct, the artificial microRNA sequence was designed with the Web MicroRNA Designer platform (<http://wmd3.weigelworld.org>). The microRNA sequence was engineered using the pRS300 plasmid as template, and together with the FAMA promoter, was subcloned into the destination vector pGWBI ([@bib30]). The constructs *FAMAp:FAMA-MYC* and *FAMAp:RBR-MYC* were generated with the tripartite recombination of the plant binary vector R4pGWB419 ([@bib31]), with the Gateway entry clones of the FAMA promoter and cDNAs of FAMA or RBR. The constructs *FAMAp:SPCH-YFP*, *FAMAp:SPCH1-4A* and *FAMAp:SPCH2-4A* were generated with the plant binary vector R4pGWB430 ([@bib31]), the FAMA promoter and the respective SPCH coding sequences described in [@bib22]. Primer sequences used for each construct are provided in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}.

Transgenic plants were generated by Agrobacterium--mediated transformation ([@bib7]) and transgenic seedlings were selected by growth on 0.5 MS plates supplemented with 50 mg/l hygromycin (pHGY and pGWB1 based constructs) or kanamycin 100 mg/l (pGWB419 and pGWB430 based constructs). The constructs *FAMAp:FAMA*^*LGK*^ and *FAMAp:FAMA*^*LGK*^*-YFP* were transformed into the *fama*/+ segregating line and homozygous lines for *fama* (as detected by PCR genotyping) were recovered in subsequent generations. *FAMAp:FAMA*^*LGK*^;*fama*^−/−^ is referred to as FAMA^LGK^ throughout the study. *FAMAp:RBR-MYC* was transformed into Col and *FAMAp:FAMA*^*LGK*^*-YFP*;*fama* lines. All other constructs were transformed into Col.

Quantification of phenotypic defects in FAMA^LGK^ {#s4-3}
-------------------------------------------------

Seedlings from two independent and homozygous lines of *FAMAp:FAMA*^*LGK*^;*fama* were collected at 6, 9 and 12 dpg. Samples were cleared in 7:1 ethanol:acetic acid, treated 30 min with 1 N potassium hydroxide, rinsed in water, and mounted in Hoyer\'s medium. Differential contrast interference (DIC) images were obtained from the middle region of adaxial epidermis of cotyledons at 20× (0.32 mm^−2^ field of view) on a Leica DM2500 microscope. For quantification, 13 different guard cell phenotypes were counted and grouped into 5 classes ([Figure 1L](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Results are shown as mean percentages of each phenotypic class divided by the total number of guard cells per field view ± SEM (n = 30).

Analysis of transcriptional and translational reporters {#s4-4}
-------------------------------------------------------

To analyze reporter expression in FAMA^LGK^, *FAMAp:amiRBR* and *fama*, all transcriptional and translational reporters were introgressed into the mutant backgrounds and homozygous lines (as determined by PCR-based genotyping and segregation ratios) in subsequent generations were recovered for analysis. For confocal microscopy, images were taken with a Leica SP5 microscope and processed in ImageJ. Cell outlines were visualized by either 0.1 mg/ml propidium iodide in water (Molecular Probes, P3566) or the plasma membrane marker ML1p:mCherry-RCI2A. GUS staining of transcriptional reporters was performed as described in [@bib42] and seedlings were mounted in Hoyer\'s and visualized with DIC microscopy as described above.

Timelapse imaging {#s4-5}
-----------------

After 6 days of growth on half strength MS media, seedlings were transferred to a sterilized perfusion chamber similar to that described in [@bib38] for imaging on a Leica SP5 Confocal microscope. The chamber was perfused with ¼ strength 0.75% (wt/vol) sucrose liquid MS growth media (pH 5.8) at a rate of 2 ml/hr. Z-stacks through the epidermis of the reporter lines were captured with Leica software every 20 min (SPCH) or 2 hr (MUTE) and then processed with Fiji/ImageJ (NIH).

Bimolecular Fluorescence Complementation (BiFC) assays {#s4-6}
------------------------------------------------------

Full-length ORFs with no stop codon of each test candidate (FAMA, FAMA^LGK^, bHLH93, RBR, CYCD and CYCD^LGK^) were cloned into BiFC vectors ([@bib44]) to generate fusion proteins with either N or C terminal half of the yellow fluorescence protein (YFP) fused to the C-terminus of the test candidate. FAMA and bHLH93 constructs were reported in ([@bib34]). Assays were performed in *Nicotiana benthamiana* leaves as described in [@bib34]. BiFC signals were visualized on a Leica DM5000 fluorescence microscope and quantified as percentage of YFP-positive nuclei over total number of pavement cells in a field of view (centered on the injection site). Results from three experiments are presented in [Figure 1G](#fig1){ref-type="fig"}.

Yeast two-hybrid assays {#s4-7}
-----------------------

Full-length ORFs containing stop codons for each test candidate (FAMA, FAMA^LGK^, bHLH93, BASL, RBR, CYCD, CYCD^LGK^) were cloned into pENTR/D-TOPO (Life Technologies) and then recombined into the yeast vectors pGADT7 (Clontech, Mountain View, CA) and pXDGATcy86 ([@bib11]) Yeast stain AH109 was transformed using the Yeastmaker yeast transformation system (Clontech) according to manufacture\'s instructions. Pairwise interactions were tested based on growth complementation on nutritional selective media.

Quantitative RT-PCR {#s4-8}
-------------------

Cotyledons from 10 FAMA^LGK^ or Col seedlings were harvested at 12 dpg and RNA was extracted using the RNeasy plant mini kit (QIAGEN, Valencia, CA) with on-column DNAse digestion. 700 ng of total RNA was used for cDNA synthesis using oligo(dT) primers and the Supercript III First-strand cDNA synthesis kit (Life Technologies). qPCR reactions were performed on a CFX96 Real-Time PCR detection system (Bio-Rad) with the Ssofast EvaGreen Supermix (Bio-Rad, Hercules, CA). Three technical replicates were performed on each of two biological replicates. Expression values were normalized to the reference gene ACTIN2 using the Δ^CT^ method and relative expression of a target was calculated from the ratio of FAMA^LGK^ to Col. All data are presented as mean ± SEM. The significance of difference between the mean values was determined using two-tailed unpaired Student\'s *t* test. Statistical analysis was applied to normalized Δ^CT^ values. p \< 0.05 was considered statistically significant. All calculations were performed using GraphPad Prism software. Primer sequences are listed in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. Since expression of the embryonic genes *WOX9*, *LEC1*, *FUS3* and the shoot apical meristem gene *STM* were not detectable in cotyledons of either Col nor FAMA^LGK^, we confirmed that primers were functional by testing them in RT-PCRs with RNA from immature siliques, as described in [@bib35]. *STM*, *WOX9*, *LEC1* and *FUS3* were all detectable in these assays ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

Chromatin immunoprecipitation (ChIP) assays {#s4-9}
-------------------------------------------

ChIP experiments were carried out based on standard protocols ([@bib12a]) or with adaptations as described in [@bib24]. Briefly, for ChIPs of FAMA, ∼5 g of 5-day-old whole seedlings of FAMAp:FAMA-MYC (in Col or in *fama*) and Col (control) were used as starting materials. For ChIPs of RBR, ∼25 g of 5-day-old whole seedlings of Col (control) and FAMAp:RBR-MYC in Col or in FAMApro::FAMA^LGK^-YFP;*fama* were used in the assays. For RBR ChIP, input materials were processed in standard-sized aliquots during nuclei isolation and DNA fragmentation steps before combining for immunoprecipitation. Expression and pull-down of the cell-type specific RBR-Myc were verified by Western and immunoprecipitation experiments ([Figure 5---figure supplement 2A--B](#fig5s2){ref-type="fig"}). Chromatin was fragmented by a Bioruptor (Diagenode) programed at high intensity for 3 × 7.5 min (cycles of 30 s on and 30 s off) at 4°C. Immunoprecipitation was carried out with a monoclonal anti-Myc antibody (71D10; Cell Signaling Technology), followed by incubation with magnetic beads (Dynabeads Protein A; Invitrogen). ChIPed DNA was purified by the ChIP DNA Clean & Concentrator (Zymo). For real-time qPCR, reactions were performed using SsoFast EvaGreen or SsoAdvanced Universal SYBR Green Supermix (Bio-Rad), according to manufacturer\'s recommended conditions, with primers targeted to the indicated region of selected genes ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}) on a CFX96 Real-Time PCR detection system (Bio-Rad). CT values were obtained for sonicated chromatin taken before (input) and after immunoprecipitation (ChIP). Three technical replicates were assayed for each sample. CT values for ChIP DNA were normalized to mean of CT values for input DNA (CT ChIP---μCT Input). Fold enrichment was calculated by dividing the normalized value of Myc-tagged with that of untagged Col. All data are presented as mean ± SEM. Two biological replicates were assayed for each ChIP-qPCR experiment.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "Irreversible fate commitment in the Arabidopsis stomatal lineage requires a FAMA and RETINOBLASTOMA-RELATED module" for consideration at *eLife*. Your article has been favorably evaluated by Detlef Weigel (Senior editor), Richard Amasino (Reviewing editor), and 2 reviewers.

The Reviewing editor and the reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

1\) Regarding the ChIP experiments, it would be useful to do some further analyses at higher resolution. It is unclear if the target sites amplified by qPCR overlap for RBR and FAMA at the present resolution. Furthermore, an important control that should be done for at least a few of the target genes, is to generate ChIP data across several neighboring regions to ensure that the peak is real and decaying as expected.

2\) In addition, please show the results from at least two biological replicates (i.e., double the number of columns in the relevant histograms).

3\) Regarding the statistical treatment of the ChIP-qPCR data, rather than apply standard statistics to ratios (i.e., the normalized values), it is more appropriate to compare ratios in the ChIP-qPCR assays (tagged sample vs Col-0 control) by multiplying the standard errors of the individual results. (The errors seem small enough that the differences will hopefully still be significant, but it would be good to know that this is the case.) An ANOVA is also possible (with the CT values themselves) as is a linear regression with the Ct of the sample plotted against the Ct of the control to enable a determination of the correlation of the Ct of Col against the Ct of the control (and a p-value can be obtained for the linear regression).

4\) The arguments for the statement "we largely uncoupled division and fate modulating roles of RBR" and the claim that cells do not return to an embryonic identity or earlier stem cell identity need to be more thoroughly discussed. Furthermore, the relatively easy experiment of evaluating TMO7 and WOX2 expression in marker lines to support the above statements ought to be done.

5\) It is important to note whether or not pRBR-RBR-CFP rescues the rbr null mutants.

6\) Regarding the claim that your data demonstrate the dosage sensitivity of RBR\'s cell-cycle repression activity, it is important to show that RBR levels are unaltered in FAMA-LGK mutants. Also, given the highly specific RBR accumulation pattern, qRT may not be sufficient to address this issue. Preferable, an RBR-reporter line would be used.

7\) Regarding the pFAMA-RBR-Myc line that is used for their lineage-specific ChIP, it is important to note whether or not expression of this construct affects stomatal development because differentiation appears to be highly dependent on RBR dosage.

8\) Regarding "These results reinforce parallels between stem-cell decisions in plants and animals at molecular and organizational levels\..." There are clearly parallels in how plants and animals organize stem cells, but it is not clear what mechanism in particular you have identified in this study that reinforces this idea. This part should be further developed or removed.

10.7554/eLife.03271.019

Author response

*1) Regarding the ChIP experiments, it would be useful to do some further analyses at higher resolution. It is unclear if the target sites amplified by qPCR overlap for RBR and FAMA at the present resolution. Furthermore, an important control that should be done for at least a few of the target genes, is to generate ChIP data across several neighboring regions to ensure that the peak is real and decaying as expected*.

We have generated new ChIP data for FAMA and RBR on several regions of the *SPCH* and *EPF1* loci and show that the binding peaks are restricted to the proximal promoter regions of these genes and decay as expected. The FAMA binding peak is sharper than that of RBR, but the overlap is strong. These studies suggest that FAMA and RBR do indeed bind to the same region and are provided in [Figure 5--figure supplement 3](#fig5s3){ref-type="fig"}).

*2) In addition, please show the results from at least two biological replicates (i.e., double the number of columns in the relevant histograms)*.

We have repeated all of the ChIP experiments starting from new plant material. We found that in the context of this figure, showing both replicates on the same axes made them very difficult to read. Instead, we provide results from the biological replicates in [Figure 5--figure supplement 4](#fig5s4){ref-type="fig"}. These replicates show similar enrichments to the original ones, with the exception of RBR association with *EPF1* in a FAMA^LGK^ background (in the new replicate, RBR binding is also reduced here). We address this variation in the text.

*3) Regarding the statistical treatment of the ChIP-qPCR data, rather than apply standard statistics to ratios (i.e., the normalized values), it is more appropriate to compare ratios in the ChIP-qPCR assays (tagged sample vs Col-0 control) by multiplying the standard errors of the individual results. (The errors seem small enough that the differences will hopefully still be significant, but it would be good to know that this is the case.) An ANOVA is also possible (with the CT values themselves) as is a linear regression with the Ct of the sample plotted against the Ct of the control to enable a determination of the correlation of the Ct of Col against the Ct of the control (and a p-value can be obtained for the linear regression)*.

Thank you for this very thought-provoking comment. These calculations were new to us, so in our attempts to educate ourselves about statistical treatment of ChIP-PCR data, we consulted with colleagues and gathered information from publications. We found that statistical tests on ChIP-qPCR data are actually very uncommon (e.g. none performed in Sawa M et al., Science, 2007; Pruneda-Paz JL et al., Science, 2009; [@bib45]; and Yu T et al., eLife, 2013). One possible reason is that due to the "sticky" nature of tagged samples, negative control regions may sometimes be called as significantly enriched (statistically) in ChIPed DNA from tagged samples when compared to WT samples, creating false-positives. Thus, most studies use enrichment level at the negative control regions as the baseline to assess binding events.

We debated how to make the clearest presentation of the data. To conform to current standards and avoid confusion, we removed the statistical tests in our ChIP-qPCR data altogether. We did calculate S.E.M. for the normalized CT values and included this in the figures. We think the additional ChIP data provided in this revision (at higher resolution and on neighboring regions, and with biological replicates) provide compelling data to support our conclusions about FAMA and RBR binding. We did include an expanded version for our ChIP-qPCR data analysis in the methods section: CT values were obtained for sonicated chromatin taken before (input) and after immunoprecipitation (ChIP). Three technical replicates were assayed for each sample. CT values for ChIP DNA were normalized to mean of CT values for input DNA (CT ChIP -- μCT Input). Fold enrichment was calculated by dividing the normalized value of MYC-tagged with that of untagged Col. All data are presented as mean ± SEM.

However, should the editor and reviewer wish to have us keep the measurements of significance in the manuscript, we did calculate significance by t-test and included the t-test calculations here in the response ([Author response image 1](#fig6){ref-type="fig"}) and also attempted to address the error propagation issue. Although the reviewer suggested doing an ANOVA instead of a t-test, since we are comparing only two independent samples (tagged vs. untagged) and all of our readings indicated that ANOVA is used when comparing three or more means for statistical significance, we choose to use the two-tailed unpaired Student's t-test to determine whether normalized ChIP-qPCR values for MYC-tagged sample and untagged Col control were significantly different from one another. Should the reviewer and editor decide that these calculations are acceptable, it would be simple to substitute the graphs in [Author response image 1](#fig6){ref-type="fig"} (below) for those currently in [Figure 5](#fig5){ref-type="fig"}.Author response image 1.Student's t-test analysis of ChIP-qPCR data presented in [Figure 5B-D](#fig5){ref-type="fig"}. Statistical analysis was applied to normalized CT values. P\<0.05 was considered statistically significant. Red arrows indicate P-values not considered statistically significant when error propagation of normalized CT values is taken into account.

The error propagation analysis is used to obtain the standard error of a new parameter (i.e. normalized values in our case) that is calculated from other parameters with standard errors (i.e. dCT). Bellow we show our ChIP-qPCR data calculation. We didn't find an example in the literature for incorporation of error propagation for ChIP-qPCR data analysis. However, we did try to develop this for our analysis by consulting colleagues and J.R. Taylor, An Introduction to Error Analysis (University Science Books, 1982), Chapter 3, Propagation of uncertainties.

The propagated S.E.M. are shown in italics.

1\) Mean of CT values from qPCR signals:

Input WT = **μCTiw** ± **εiw**

ChIPed WT = **μCTcw** ± **εcw**

Input Myc-tagged = **μCTim** ± **εim**

ChIPed Myc-tagged = **μCTcm** ± **εcm**

All our errors (ε) represent S.E.M.

2\) Normalization of ChIPed qPCR values to input qPCR values:

NCTw = **μCTiw** -- **μCTcw** ± ***εNCTw***

NCTm = **μCTim** -- **μCTcm** ± ***εNCTm***

***εNCTw and εNCTm*** *can be propagated as:*

***εNCTw = εiw + εcw εNCTm*** *=* ***εim + εcm***

All our errors (ε) represent S.E.M.

3\) Fold enrichment calculation:

NCTw/NCTw = 1 NCTm/NCTw = fold enrichment

*4) The arguments for the statement "we largely uncoupled division and fate modulating roles of RBR" and the claim that cells do not return to an embryonic identity or earlier stem cell identity need to be more thoroughly discussed. Furthermore, the relatively easy experiment of evaluating TMO7 and WOX2 expression in marker lines to support the above statements ought to be done*.

We have added text in the results and discussion sections to flesh out these statements more fully. In regards to embryonic identity, we, too, prefer using marker lines to obtain cellular resolution of expression patterns when possible. In the case of the experiments done in our manuscript, it is important to realize that these are in a genetic background of *fama-/-*; *FAMAp:FAMA-LGK* +/+; *ML1-RFP*; +/- or +/+, all of which come with their own antibiotic resistances. Because many markers show dose sensitivity, we prefer crossing in a common marker, and introgressing new markers into this background in not a fast process when considering all of the genotypes. For these reasons we also optimized a qPCR experiment (using all of the markers we had already confirmed as positive controls) that would let us more easily monitor other genes. As shown in [Figure 4](#fig4){ref-type="fig"}, genes that become expressed in FAMA^LGK^ "reprogrammed" cells, are significantly increased. Thus we feel that this assay has the sensitivity needed to detect transcripts of other genes, should they become expressed here.

In terms of genes to monitor "embryonic" or "meristem" identity, we initially chose a much larger number of genes described as such in publications. However, when looking at these genes in other manuscripts or in expression profile s of multiple tissues, we found that very few could actually be described as truly restricted to just one developmental stage. For example, the *TMO7* gene requested by the reviewer seems like a great choice from Dolf Weijer's papers. But *TMO7=PRE3* and this gene is expressed in young leaves (see [Author response image 2](#fig7){ref-type="fig"} from the Bellini lab), so we would not be able to conclude from monitoring its expression whether cells had an early epidermal or meristem identity.Author response image 2.

WOX2 and WOX8 were reported to be expressed in the egg cell and in the zygote \[Haecker, et al, Development, 2003\]. *WOX8* is also expressed in cotyledons so we cannot use it, but *WOX2* does seem to be exclusively embryonic so we included this in our expanded qRT-PCR panel. We requested WOX2 reagents and recently received plasmid that we were able to transform into *fama*-/-; *FAMAp:FAMA*^*LGK*^ +/+; *ML1-RFP*; +/- and WT lines, but as it will be at least 4 months before we could confidently determine the expression pattern in stable T2 lines and we already found that *WOX2* was not upregulated in FAMA^LGK^ leaves by qRT-PCR (now in [Figure 4A](#fig4){ref-type="fig"}), we did not think it was worthwhile to delay this paper for the extra months.

*5) It is important to note whether or not pRBR-RBR-CFP rescues the rbr null mutants*.

In this paper, we use pRBR-RBR-CFP only to demonstrate that the protein is in many cells, including the stomatal lineage. Perhaps the reviewer is making the important point that for functional studies like ChIP, one should be using a functional construct, but because our ChIP construct (FAMAp:RBR-MYC) is only expressed in the late stomatal lineage and RBR is an essential gene, we cannot assay rescue with it.

All RBR reagents were constructed with the same RBR coding sequence and this coding sequence was shown to rescue rbr in (Cruz-Ramírez et al., 2013, Plos biology) In addition, a C-terminal RFP-tagged version of RBR was shown previously to rescue the rbr mutant defects, suggesting that tagging RBR at its C-terminus, as in our study, does not impair RBR function (Ingouff et al., Plant Cell, 2006). We have included this information and the Cruz-Ramírez references in the revised text.

*6) Regarding the claim that your data demonstrate the dosage sensitivity of RBR\'s cell-cycle repression activity, it is important to show that RBR levels are unaltered in FAMA-LGK mutants. Also, given the highly specific RBR accumulation pattern, qRT may not be sufficient to address this issue. Preferable, an RBR-reporter line would be used*.

RBR is expressed in all cells in the plant. This comment makes us realize that with our choice of images to show that RBR is present in the stomatal lineage ([Figure 1C](#fig1){ref-type="fig"}), we may have given the wrong impression that RBR was specific to only those cells (if we were to focus into another plane, you would see expression in other cells as shown in previously published work). We have reemphasized that RBR is in all young epidermal cells in the text.

We have included an image of RBRp:RBR-CFP in the FAMA^LGK^ background as [Figure 4](#fig4){ref-type="fig"}. We see no evidence for broadened expression pattern or extended expression in pavement cells, nor for diminished expression in GCs. In the reprogrammed GCs we would actually expect RBR to be up-regulated (re-expressed) as a consequence of these cell's division behavior as well as because RBR is a target of SPCH (see [Author response image 3](#fig8){ref-type="fig"}). This is what we observe ([Figure 4 D-G](#fig4){ref-type="fig"}) Importantly, we also show that neither RBRpro:RBR-CFP nor FAMApro:RBR-MYC is sufficient to repress (or promote) GC divisions in a WT background ([Figure 4A-B](#fig4){ref-type="fig"} and [Figure 5--figure supplement 2 C-F](#fig5s2){ref-type="fig"}, respectively).Author response image 3.

*7) Regarding the pFAMA-RBR-Myc line that is used for their lineage-specific ChIP, it is important to note whether or not expression of this construct affects stomatal development because differentiation appears to be highly dependent on RBR dosage*.

We have included an analysis of FAMAp:RBR-MYC phenotypes and expression in [Figure 5--figure supplement 2 C-F](#fig5s2){ref-type="fig"}. We find no evidence for the reiteration of early stomatal lineage behaviors in these GCs, nor do we find suppression of divisions in the GC precursor.

*8) Regarding "These results reinforce parallels between stem-cell decisions in plants and animals at molecular and organizational levels\..." There are clearly parallels in how plants and animals organize stem cells, but it is not clear what mechanism in particular you have identified in this study that reinforces this idea. This part should be further developed or removed*.

We have changed the last two paragraphs of the paper to explain more about the RBR division effects. We make specific references to parallels between myogenic and stomatal lineage in terms of bHLHs, kinases and Rb/RBR and cite literature that discussed this more fully.
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